From Caution To Consideration: Why Analyst Is More Optimistic On Kimberly-Clark And Clorox Now
Portfolio Pulse from Shivani Kumaresan
Bernstein analyst Callum Elliott has upgraded the rating on Kimberly-Clark Corporation (KMB) and Clorox Company (CLX) to Market-perform from Underperform. Despite a solid performance, KMB's stock has underperformed by 23% YTD, leading to a downward target price revision to $118 from $125. CLX's stock is down 22% over the past six weeks, driven by a cyber-attack in mid-August. The analyst expects further bad news with 1Q results in November.
October 12, 2023 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Clorox's stock is down 22% over the past six weeks, driven by a cyber-attack in mid-August. The analyst expects further bad news with 1Q results in November.
The analyst's upgrade is based on the company's recent struggles, including a cyber-attack that has negatively impacted the stock price. Further bad news is expected with the 1Q results.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Kimberly-Clark's stock has underperformed by 23% YTD, leading to a downward target price revision to $118 from $125.
The analyst's upgrade is based on the company's solid performance this year. However, the stock has underperformed, leading to a downward revision of the target price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100